Pfizer Inc. buy BMO Capital Markets
Start price
16.10.23
/
50%
€31.50
Target price
16.10.24
€31.25
Performance (%)
-13.29%
End price
17.10.24
€27.32
Summary
This prediction ended on 17.10.24 with a price of €27.32. The price of Pfizer Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -13.29%. A total of €1.93 was paid as dividends for this prediction. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Pfizer Inc. | -1.801% | -1.801% | -14.708% |
| iShares Core DAX® | -1.410% | 0.471% | 12.651% |
| iShares Nasdaq 100 | -0.450% | -0.305% | 5.495% |
| iShares Nikkei 225® | -0.224% | 5.529% | 18.894% |
| iShares S&P 500 | -1.095% | -0.774% | 1.350% |
Comments by BMO_Capital_Markets for this prediction
In the thread Pfizer Inc. diskutieren
Pfizer Inc. (NYSE: PFE) had its price target lowered by analysts at BMO Capital Markets from $44.00 to $33.00. They now have an "outperform" rating on the stock.
Ratings data for PFE provided by MarketBeat
In the thread Trading Pfizer Inc.
Die von BMO_Capital_Markets gewählte maximale Laufzeit wurde überschritten